한글목차

세계 자간전증 진단 시장은 2025년에 23억 2,000만 달러, 2032년에는 46억 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 10.3%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.

그림. 2025년 지역별 자간전증 진단 시장 점유율(%)

자간전증은 임신 20주 이후 고혈압과 소변 내 단백뇨를 특징으로 하는 임신 합병증입니다. 이 질환을 발견하지 못하면 산모와 태아에게 위험한 상태가 될 수 있습니다. 임상의가 상태를 주의 깊게 관찰하고 자간전증이 악화될 경우 아기를 출산하기 위해서는 조기 진단이 매우 중요합니다. 기존의 진단 방법은 임상 증상과 징후에 의존하고 있으며, 이는 한계가 있습니다. 자간전증 진단 시장은 이 질환에 대한 인식이 높아짐에 따라 성장 가능성이 높습니다. 다양한 새로운 진단 도구가 개발 및 채택되어 위험에 처한 여성을 선별하고 질병을 적시에 식별할 수 있도록 돕고 있습니다.

시장 역학

세계 자간전증 진단 시장의 성장은 전 세계적으로 자간전증 유병률이 증가하고 있는 것이 원동력이 되고 있습니다. 최근 추정에 따르면, 임신성 고혈압성 신증은 전 세계 임신의 약 5-8%를 차지합니다. 초산부 연령이 높아지는 것도 발병률 증가에 기여하고 있습니다. 신제품 출시와 조기 검진을 위한 첨단 진단 기술의 채택 증가는 시장 성장의 기회를 제공합니다. 그러나 저소득 지역에서는 자간전증에 대한 인식이 낮고, 보편적 의료보험 제도가 미비한 점이 시장 성장에 걸림돌이 될 수 있습니다. 특히 가격에 민감한 신흥국 시장에서는 새로운 진단 기기의 높은 비용이 문제가 될 수 있습니다.

본 조사의 주요 특징

• 세계의 자간전증 진단 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 정리하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서에서는 기업 개요, 제품 포트폴리오, 주요 특징, 주요 성과, 전략 등의 매개 변수를 기반으로 세계 자간전증 진단 시장의 주요 기업 프로파일을 제공합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 자간전증 진단 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 자간전증 진단 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금조달과 투자
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 자간전증 진단 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• 시장에 대한 COVID-19의 영향

제5장 세계의 자간전증 진단 시장, 검사 유형별, 2020년-2032년(10억 달러)

• 혈액검사
• 소변검사
• 기타

제6장 세계의 자간전증 진단 시장, 제품 유형별, 2020년-2032년(10억 달러)

• 기기
• 소모품

제7장 세계의 자간전증 진단 시장, 최종사용자별, 2020년-2032년(10억 달러)

• 병원
• 전문 클리닉
• 진단센터
• 기타

제8장 세계의 자간전증 진단 시장, 지역별, 2020년-2032년(10억 달러)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Roche Diagnostic
  • Thermo Fisher Giving Inc.
  • PerkinElmer
  • Siemens Healthineers
  • Abbott Laboratories
  • Beckman Coulter
  • Becton, Dickinson and Company(BD)
  • bioMerieux
  • F. Hoffmann-La Roche Ltd
  • Metabolomic Diagnostics Ltd
  • Diabetomics, Inc.
  • Quidel Corporation
  • Sera Prognostics
  • Brahms GmbH
  • The Progenix Group

제10장 애널리스트 추천 사항

• 기회
• 애널리스트의 견해
• Coherent Opportunity Map

제11장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Preeclampsia Diagnostics Market is estimated to be valued at USD 2.32 Bn in 2025 and is expected to reach USD 4.60 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.3% from 2025 to 2032.

Figure. Preeclampsia Diagnostics Market Share (%), By Region 2025

Preeclampsia is a pregnancy complication characterized by high blood pressure and presence of protein in the urine after 20 weeks of gestation. It can be a dangerous condition for both mother and baby, if undetected. Early diagnosis is crucial to allow clinicians to closely monitor the condition and deliver the baby if preeclampsia worsens. Traditional diagnostic methods rely on clinical signs and symptoms, which have limitations. Global preeclampsia diagnostics market can witness growth due to increasing awareness about the condition. Various new diagnostic tools are being developed and adopted to screen women at risk and enable timely identification of the disorder.

Market Dynamics:

Global preeclampsia diagnostics market growth is driven by growing incidence of preeclampsia worldwide. According to recent estimates, preeclampsia complicates around 5-8% of all pregnancies globally. Rising maternal age of first-time mothers can contribute to its rising caseload. New product launches and increasing adoption of advanced diagnostic technologies for early screening can offer opportunities for market growth. However, limited awareness about preeclampsia in low income regions and lack of universal healthcare can hamper the market growth. High cost of new diagnostic devices can pose challenge, especially in price-sensitive developing markets.

Key Features of the Study:

• This report provides in-depth analysis of the global preeclampsia diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global preeclampsia diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Roche, Thermo Fischer Scientific, Bayer, Siemens Healthineers, DRG Instruments GmbH
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global preeclampsia diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preeclampsia diagnostics market

Detailed Segmentation-

• By Test Type
  • Blood Tests
  • Urine Analysis
  • Others
• By Product Type
  • Instruments
  • Consumables
• By End User
  • Hospital
  • Specialty Clinics
  • Diagnostic Centers
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Roche Diagnostic
  • Thermo Fisher Giving Inc.
  • PerkinElmer
  • Siemens Healthineers
  • Abbott Laboratories
  • Beckman Coulter
  • Becton, Dickinson and Company (BD)
  • bioMerieux
  • Hoffmann-La Roche Ltd
  • Metabolomic Diagnostics Ltd
  • Diabetomics, Inc.
  • Quidel Corporation
  • Sera Prognostics
  • Brahms GmbH
  • The Progenix GrouP

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Test Type
  • Market Snapshot, By Product Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Preeclampsia Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Preeclampsia Diagnostics Market, By Test Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Blood Tests
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Urine Analysis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Preeclampsia Diagnostics Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Instruments
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Consumables
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Preeclampsia Diagnostics Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Preeclampsia Diagnostics Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Roche Diagnostic
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Giving Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • PerkinElmer
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Siemens Healthineers
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott Laboratories
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Beckman Coulter
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Becton, Dickinson and Company (BD)
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • bioMerieux
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Metabolomic Diagnostics Ltd
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Diabetomics, Inc.
  • Quidel Corporation
  • Sera Prognostics
  • Brahms GmbH
  • The Progenix Group

10. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact